MBF Therapeutics is a life science company developing and commercializing proprietary checkpoint inhibitor immunotherapy technology for cancer and infectious diseases in both animal and human health.
Location: United States
Employees: 1-10
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Ben Frankl... | sep.benfra... |
Mentions in press and media 5
| Date | Title | Description |
| 23.07.2020 | Can an Animal Vaccine Developer be the One to Tame Covid-19? MBF Therapeutics Places its Bet | The collaboration with MRIGlobal, Rymedi, SSI Strategy and Aldevron will seek to advance MBF Therapeutics’ SARS CoV-2 vaccine candidate COVE-001. Financial terms of the partnership are being kept confidential. “Our goal is a better long-ter... |
| 14.01.2020 | Smithfield Foods Taps Montco Animal Health Firm to Save its Bacon | MBF Therapeutics Inc., a Montgomery County company developing DNA-based immunotherapeutic vaccines for animals, has signed an agreement with Smithfield Foods to collaborate on new swine vaccines. Their goal is to develop swine vaccines with... |
| 07.08.2019 | Montco Pet Medicine Company Licenses Immunotherapy Technology From UNC | Financial terms of the deal are being kept confidential. The agreement, which covers animal health applications of the technology, will allow MBF Therapeutics of Ambler to evaluate UNC’s checkpoint inhibitor traps and calcium phosphate nano... |
| 16.05.2018 | Ben Franklin Approved 2M in 10 Early Stage Companies | |
| 01.12.2016 | MBF Therapeutics Teams Up With Wistar | A Montgomery County company seeking to develop ways to treat cancer in dogs and cats has secured a new partner and new investment to help it achieve its goals. The company — whose name is an acronym for Man’s Best Friend — also formed a col... |